Evidence map›Paper›PMID 42376315›Full record

ArticleFrontiers in cellular and infection microbiology2026

Bacterial pathogen spectrum and antimicrobial resistance in positive pus cultures from hospitalized patients at a maternal and child healthcare specialty hospital in Shenzhen, China, 2021-2025.

Tongyan Ding, Xiaochun Liu, Futing Liao, Shaoxiang Lin, Shuyan Liu, Shujuan Yang, Xiaojie Zhou, Qiaoxin Zhang, Zhenwen Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tongyan DingClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Xiaochun LiuClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Futing LiaoClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Shaoxiang LinClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Shuyan LiuClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Shujuan YangClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Xiaojie ZhouClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.
Qiaoxin ZhangThe First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zhenwen ZhouClinical Laboratory, Key Laboratory of Bacterial Antimicrobial Resistance and Prevention, Medical Research Institute of Maternal and Child, Longgang District Maternity & Child Healthcare Hospital of Shenzhen City (Affiliated Shenzhen Women and Children's Hospital (Longgang) of Shantou University Medical College), Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Pus culture and antimicrobial susceptibility testing play an important role in pathogen identification and the adjustment of empirical therapy for localized suppurative infections. This study aimed to investigate the distribution of major bacterial pathogens isolated from pus cultures and their susceptibility profiles to commonly used antimicrobial agents among hospitalized patients at Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, in order to provide evidence for rational clinical antimicrobial use. Methods: We retrospectively collected pus culture records and aggregated antimicrobial susceptibility data from January 1, 2021 to December 31, 2025. Results: From 2021 to 2025, 586 non-duplicate bacterial isolates were recovered from positive pus cultures, of which 64.7% were Gram-negative and 35.3% were Gram-positive. The leading isolates were Conclusions: Empirical antimicrobial therapy for localized suppurative infections in this maternal and child healthcare specialty hospital should be guided by local pathogen distribution and antimicrobial susceptibility surveillance, with coverage for both Enterobacterales and staphylococci.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialAdultChildChild, PreschoolChinaFemaleHospitals, MaternityHospitals, SpecialHumansInfantMaleMicrobial Sensitivity TestsRetrospective StudiesAnti-Bacterial AgentsThird Generation Cephalosporinsantimicrobial susceptibility profileEscherichia colimaternal and child healthcare specialty hospitalpathogenspus culture

Identifiers

PMID42376315
PMCPMC13311103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.